Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
06/1996
06/06/1996CA2205950A1 Substituted 2-(phosphinyloxymethyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
06/06/1996CA2205800A1 2-(2,3,5,6-tetrafluoro-4-pyridyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
06/06/1996CA2205799A1 2-substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
06/06/1996CA2205577A1 Hindered n-oxide esters of rapamycin and their use as medicaments
06/05/1996EP0714912A2 GMP-140 derived lektin-like domain peptides and their ligands
06/05/1996EP0714903A1 New carbohydrate conjugates as cell adhesion inhibitors
06/05/1996EP0714895A1 Pyrrole derivatives
06/05/1996EP0714449A1 Oligonucleotide modulation of protein kinase c
06/05/1996EP0714408A1 Tryptase inhibitor
06/05/1996EP0714404A1 Anti-inflammatory peptides
06/05/1996EP0714397A1 Phenethylamine compounds
06/05/1996EP0714386A1 Water-soluble nimesulide salt, and uses thereof for the treatment of inflammations
06/05/1996EP0714294A1 Pharmaceutical compositions comprising metal complexes
06/05/1996EP0714293A1 3-cyano-3-(3,4-disubstituted)phenylcyclohexyl-1-carboxylates
06/05/1996EP0714291A1 Lupane triterpenoid derivatives
06/05/1996CN1124027A Ureido derivatives of naphthalenephosphonic acids and process for their preparation
06/05/1996CN1124026A Thioindole pyperidinyl derivatives used as antalgics
06/05/1996CN1123686A Spraying agent for stopping pains
06/05/1996CN1031940C Process for preparing substituted pyrrole compounds
06/04/1996CA2019863C Aqueous pharmaceutical suspension for substantially water insoluble pharmaceutical actives
06/02/1996CA2163490A1 Pyrrole derivatives
05/1996
05/30/1996WO1996016083A1 Peptides endowed with antiinflammatory activity
05/30/1996WO1996016075A1 Antibiotic cryptdin peptides and methods of their use
05/30/1996WO1996016041A1 Heteroaryl-substituted deoxy glycero-phosphoethanolamines
05/30/1996WO1996016027A1 Matrix metalloprotease inhibitors
05/30/1996WO1996015810A1 Monofunctional and/or polyfunctional polylysine conjugates
05/29/1996EP0713698A2 Medical use of atypical beta-adrenoceptor agonists
05/29/1996EP0713697A1 Analgesic anti-inflammatory adhesive preparations
05/29/1996EP0713653A1 Fortified fruit juice
05/29/1996EP0713495A1 Methods of enhancing bioactivity of chemokines
05/29/1996EP0713483A1 Amidine derivatives with nitric oxide synthetase activities
05/29/1996EP0713396A1 Medical use of stem bromelain protease
05/29/1996EP0713386A1 Spray formulation having a cooling effect
05/29/1996EP0506778B1 Substituted 4-phenyl-4-piperidinecarboxamides with both local anaesthetic and analgesic effect as well as processes for their preparation
05/29/1996EP0506658B1 Compositions and method for treating painful, inflammatory or allergic disorders
05/29/1996EP0469065B1 Recombinant antibody-toxin fusion protein
05/28/1996US5521315 Olefin substituted long chain compounds
05/28/1996US5521220 Treating inflammatory and central nervous system disorders
05/28/1996US5521213 Nonsteroid antiinflammatory agents
05/28/1996US5521194 Antiproliferative agent for restenosis treatment
05/28/1996US5521185 Methods for inhibiting graft rejection and IL-1 production
05/28/1996US5521156 Cyclic neurokinin A antagonists
05/28/1996CA2041330C Percutaneously absorbable eperisone or tolperisone preparation
05/28/1996CA1338352C 2-substituted quinolines
05/24/1996CA2163466A1 Fortified fruit juices
05/23/1996WO1996015153A1 Human antibodies to t-cell receptor peptides and methods for their preparation
05/23/1996WO1996015126A1 Furan derivatives for inhibiting pneumocystis carinii pneumonia, giardia lamblia and cryptosporidium parvum
05/23/1996WO1996015123A1 Pyridine modulators of acetylcholine receptors
05/23/1996WO1996015106A1 Aryloxycycloalkenyl and aryloxyiminocycloalkenylhydroxyureas as 5-lipoxygenase inhibitors
05/23/1996WO1996014876A1 Yeast-based delivery vehicles
05/23/1996WO1996014844A1 Cyclic amidine analogs as inhibitors of nitric oxide synthase
05/23/1996CA2205138A1 Human antibodies to t-cell receptor peptides and methods for their preparation
05/23/1996CA2204898A1 Methods of inhibiting pneumocystis carini pneumonia, giardia lamblia, and cryptosporidum parvum and compounds useful therefor
05/22/1996EP0712631A2 Cyclosporin containing multiple emulsions
05/22/1996EP0712390A1 Succinamide derivatives, processes for their preparation and their use as gelatinase and collagenase inhibitors
05/22/1996EP0712389A1 Therapeutic compound - fatty acid conjugates
05/22/1996CN1123005A Compositions, for inhibition, control and regression of angiogenesis, containing hyaluronic acid and nsaid
05/22/1996CN1031826C Pyrazolopyrimidine and pyrimidinyl bisphosphonic esters as anti-inflammatories
05/21/1996US5519163 Inhibitors of phosphoinositide-specific phospholipase C
05/21/1996US5519134 Pyrrolidine-containing monomers and oligomers
05/21/1996US5519036 Cyclic derivatives pharmaceutical compositions containing these compounds and processes for preparing them
05/21/1996US5519022 α, α dialkylbenzyl derivatives
05/21/1996US5519008 Antiinflammatory agents
05/21/1996US5518999 Method for treating Kaposi's sarcoma and blocking or inhibiting vascular permeability
05/21/1996US5518911 Human PAK65
05/21/1996US5518738 Nanoparticulate nsaid compositions
05/18/1996CA2160841A1 Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors
05/17/1996WO1996014339A1 Antibodies
05/17/1996WO1996014329A1 Sugar modified nucleosides and their use for synthesis of oligonucleotides
05/17/1996WO1996014328A1 Tumor necrosis factor-gamma
05/17/1996WO1996014302A1 Pyrazole derivatives exhibiting anti-inflammatory and analgesic effects
05/17/1996WO1996004266A3 Indol, indazol, pyridopyrrol and pyridopyrazol derivatives with anti-asthmatic, anti-allergic, anti-inflammatory and immunomodulating effects
05/17/1996CA2307311A1 Sugar modified nucleosides and their use for synthesis of oligonucleotides
05/15/1996EP0711550A1 Cyclosporin-containing soft capsule compositions
05/15/1996EP0711282A1 Compounds as pde iv and tnf inhibitors
05/15/1996EP0711281A1 4-phenyl-4-phenylpropyl(enyl)-piperidines as tachykinin antagonists
05/15/1996EP0711280A1 Perhydroisoindole derivatives as p substance antagonists
05/15/1996EP0711159A1 Methods and compositions for treating asthma, atherosclerosis andinflammatory diseases using optically pure (-)-zileuton
05/15/1996DE19509279C1 Dermatomyositis-spezifisches Autoantigen Dermatomyositis-specific autoantigen
05/15/1996CN1122600A Second messenger cell signaling inhibitors
05/15/1996CN1122337A Stable crystalline (6S)-and (6R)-tetrahydrofolic acid
05/09/1996WO1996013603A1 INTERLEUKIN-1 β CONVERTING ENZYME LIKE APOPTOSIS PROTEASE-3 AND 4
05/09/1996WO1996013585A1 A novel family of protease inhibitors, and other biologic active substances
05/09/1996WO1996013517A1 Novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases
05/09/1996WO1996013500A1 Bisarylcarbinol derivatives as inhibitors of leukotriene biosynthesis
05/09/1996WO1996013491A1 Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis
05/09/1996WO1996013485A1 Pyridopyrimidones, quinolines and fused n-heretocycles as bradykinin antagonists
05/09/1996WO1996013484A1 Azetidinone derivatives for the treatment of atherosclerosis
05/09/1996WO1996013483A1 Stilbene derivatives useful as cyclooxygenase-2 inhibitors
05/09/1996WO1996013290A1 Device for aerosolized delivery of peptide drugs
05/09/1996WO1996013273A1 Pharmaceutical compositions
05/09/1996WO1996013266A1 Boronic ester and acid compounds, synthesis and uses
05/09/1996CA2203827A1 Novel family of protease inhibitors, and other biologic active substances
05/09/1996CA2203659A1 Pyridopyrimidones, quinolines and fused n-heterocycles as bradykinin antagonists
05/09/1996CA2203257A1 Device for aerosolized delivery of peptide drugs
05/09/1996CA2200462A1 Stilbene derivatives useful as cyclooxygenase-2 inhibitors
05/09/1996CA2173874A1 Novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases
05/08/1996EP0710251A1 Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices
05/08/1996EP0710241A1 Novel silylated benzylamine derivatives, salts thereof, methods of manufacture and pharmaceutical compositions containing them
05/08/1996EP0710239A1 Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines